Domů › Rakovina slinivky břišní › New York › New York City
Klinické studie Rakovina slinivky břišní v New York City, NY
60 studií pro Rakovina slinivky břišní hledá účastníky v lokalitách v New York City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Probíhá náborFáze 1/2
- Research Site, New York
- Research Site, New York
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Probíhá náborFáze 3
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Probíhá nábor
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Probíhá náborFáze 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- a dalších 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Memorial Sloan Kettering Hospital, New York
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Probíhá náborFáze 3
- Columbia University Irving Medical Center, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Probíhá náborFáze 1
- Columbia University Irving Medical Center, New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Probíhá náborObservační studie
- NYU Langone Medical Center, New York
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Probíhá náborFáze 2/3
- Icahn School of Medicine at Mount Sinai, New York
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Probíhá náborFáze 3
- Laura and Issac Perlmutter Cancer Center at NYU Langone-Ambulatory Care Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- a dalších 1
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Probíhá náborFáze 3
- Investigative Site US031, New York
- Investigative Site US003, New York
- Investigative Site US041, New York
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Probíhá náborFáze 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Probíhá náborFáze 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Probíhá náborFáze 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Probíhá náborFáze 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Probíhá náborFáze 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Probíhá náborObservační studie
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Probíhá náborFáze 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Probíhá náborFáze 2
- NYU-Manhattan, New York
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Probíhá náborFáze 1
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Probíhá nábor
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Probíhá náborFáze 1/2
- Mount Sinai Hospital, New York
- NYP/Weill Cornell Medical Center, New York
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Probíhá nábor
- NYU Langone Health, New York
- Lenox hill Hospital, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Probíhá náborFáze 1
- New York Cancer & Blood Specialists, New York
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Probíhá náborFáze 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- a dalších 2
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Memorial Sloan - Kettering Cancer Center, New York
- Memorial Sloan Kettering Basking Ridge (All protocol activities), New York
- Weill Cornell Medical Center, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- Investigative Site #103, New York
- Investigative Site #106, New York
Pancreatic Cancer Early Detection Consortium
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Irving Medical Center, New York
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Probíhá náborFáze 2
- NYU Langone Health Perlmutter Cancer Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
Probíhá náborObservační studie
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Probíhá náborFáze 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Probíhá náborFáze 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Probíhá náborFáze 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Probíhá náborFáze 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Probíhá náborFáze 1
- Columbia University Irving Medical Center, New York
Pancreatic Cancer Genetics
Probíhá náborObservační studie
- Columbia University Medical Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- Icahn School of Medicine at Mt. Sinai, New York
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Probíhá náborFáze 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Columbia University Medical Center, New York
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
Probíhá náborFáze 1/2
- Columbia University Irving Medical Center, New York
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Probíhá náborFáze 2
- Ohio State University-Telemedicine, New York
Pancreas Registry and High Risk Registry
Probíhá náborObservační studie
- Mount Sinai West, New York
- Icahn School of Medicine at Mount Sinai, New York
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Memorial Sloan Kettering Cancer Center, New York
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Probíhá náborObservační studie
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Multiparametric Ultrasound Imaging Methods
Probíhá náborVítáni zdraví dobrovolníci
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Probíhá náborFáze 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
Probíhá náborFáze 1
- Tisch Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, New York
The Cancer of the Pancreas Screening-5 CAPS5)Study
Probíhá náborFáze 3
- NYU Langone Medical Center, New York
- Columbia University Medical Center, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- Exelixis Clinical Site #5, New York
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Probíhá náborObservační studie
- Icahn School of Medicine at Mount Sinai, New York
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Probíhá náborFáze 1
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
Probíhá náborFáze 2
- Columbia University Medical Center, New York
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Probíhá náborFáze 2/3
- Columbia University Medical Center, New York
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Probíhá náborFáze 2
- Icahn School of Medicine at Mount Sinai, New York
Studie Rakovina slinivky břišní v jiných městech
- Houston, TX61 studií
- Boston, MA43 studií
- Nashville, TN39 studií
- Los Angeles, CA35 studií
- St. Louis, MO33 studií
- Arlington, VA33 studií
- Baltimore, MD31 studií
- San Antonio, TX31 studií
- Philadelphia, PA26 studií
- Tampa, FL26 studií
- Durham, NC24 studií
- San Diego, CA24 studií
Další studie v New York City
- Rakovina prsu136 studií
- Nemalobuněčný plicní karcinom121 studií
- Rakovina (všechny typy)109 studií
- Rakovina prostaty103 studií
- Metastatický karcinom93 studií
- Kolorektální karcinom78 studií
- Rakovina vaječníků69 studií
- Rakovina plic60 studií
- Mnohočetný myelom60 studií
- Rakovina endometria52 studií
- Akutní myeloidní leukemie51 studií
- Srdeční selhání51 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.